Dual time point [18F]FLT-PET for differentiating proliferating tissues vs non-proliferating tissues
Abstract Purpose For differentiating tumor from inflammation and normal tissues, fluorodeoxyglucose ([18F]FDG) dual time point PET could be helpful. Albeit [18F]FLT is more specific for tumors than [18F]FDG; we explored the role of dual time point [18F]FLT-PET for discriminating benign from malignan...
Main Authors: | Pierre Lovinfosse, Caroline Rousseau, Jean-Yves Pierga, Francis Bouchet, Alexandre Cochet, Jean-Louis Alberini, Sylvie Girault, Pierre Vera, Pierre Olivier, Lionel Uwer, Florent Cachin, Benoit Scarwell, Jérome Lemonnier, Emmanuelle Fourme, Christel Mesleard, Anne-Laure Martin, Franck Lacœuille, Olivier-François Couturier |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-12-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13550-019-0579-5 |
Similar Items
-
FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET
by: Patrick Martineau, et al.
Published: (2020-12-01) -
Diagnostic Value of 11C-Methionine (MET) and 18F-Fluorothymidine (FLT) Positron Emission Tomography in Recurrent High-Grade Gliomas; Differentiation from Treatment-Induced Tissue Necrosis
by: Takashi Tamiya, et al.
Published: (2012-03-01) -
Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
by: Alexandra Nikaki, et al.
Published: (2019-01-01) -
FLT-PET for early response evaluation of colorectal cancer patients with liver metastases: a prospective study
by: Marie Benzon Mogensen, et al.
Published: (2017-07-01) -
Clinical value of 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography for diagnosis, staging and assessing therapy response in lung cancer
by: Bandar Alwadani, et al.
Published: (2021-07-01)